Recent Finacing
Recent Raise
Celladon is a San Diego biopharma developing MYDICAR, an AAV gene therapy restoring cardiac calcium-handling enzyme to improve contractility in advanced heart failure, pursuing clinical and European programs.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors